Ledger.Open graph →
SEC Form D · Amendment · filed May 21, 2020

Good Therapeutics, Inc

Offering
$22.3M
Sold
$22.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Seattle, WA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

John Mckearn · Seattle, WADirectorNicholas Walrod · Seattle, WADirectorJohn Mulligan · Seattle, WAExec · Director · PromoterKarl Handelsman · Seattle, WADirectorMitchell Mutz · Seattle, WADirectorTodd Miller · Broomfield, COExec · Director · PromoterEimear Cowhey · Dublin, XXDirectorPiotr Biezychudek · Broomfield, CODirectorJixiang An · Athens, GADirectorBiao He · Athens, GADirectorVitaly N. Vorobeychik · New York, NYDirectorPhilip N. Vorobeychik · New York, NYDirectorKirk Brown · Vancouver, WADirectorCraig Moody · Vancouver, WAExec · Director · PromoterAmmar A. Bandukwala · Austin, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗